| New from NCI |
| How a Cancer Advocate Goes the Distance for Underserved Communities |
 |
|
Access to remote communities is a challenge, but talking about cancer is more difficult. Read about Phyllis Pettit Nassi's story as a cancer advocate and her efforts to improve access to care for underserved communities. |
| Biomarker Testing for Cancer Treatment |
 |
|
Biomarker testing is a way to look for genes, proteins, and other substances in a sample of cancer cells that can provide information about that cancer. Learn how biomarker testing may help you and your doctor choose a cancer treatment for you. |
| Pandemic Creates Problems and Opportunities for Cancer Screening |
 |
|
After a steep drop in screening for common cancers early in the COVID-19 pandemic, researchers are exploring ways to improve cancer screening during the current crisis and beyond. |
Advances in Bladder Cancer Research
Researchers are working to improve our understanding of how to treat bladder cancer. With recent advances in immunotherapy and targeted therapy, treatment for this cancer has the potential to become more effective and less toxic. |
Imaging Test Could Help Guide Breast Cancer Treatment Decisions
A new NCI-funded study shows that for some people with ER-positive breast cancer, a new imaging test may help guide decisions about receiving hormone therapy. The test can show whether estrogen receptors in tumors are active and responding to estrogen. |
| Remembering Cancer Research Greats |
 |
|
Following the death of Dr. Emil Freireich in February, NCI Director Dr. Norman E. Sharpless reflects on the achievements and legacies of Dr. Freireich and several other cancer research pioneers who have passed in recent years. |
Test Could Help Decide Who Should Get Hormone Therapy for Prostate Cancer
For some people with prostate cancer, a biomarker test called Decipher may help predict if their cancer will spread elsewhere in the body. The test could help them decide whether hormone therapy, which can cause distressing side effects, is needed. |
Hormone Therapy for Prostate Cancer
We’ve updated our page describing hormone therapy and its role in treating prostate cancer. Learn about the types of hormone therapy, how they are used, and possible side effects.
|
| FDA Approvals |
New Treatment for Lung Cancer
We’ve added a new drug summary for tepotinib hydrochloride (Tepmetko), which the Food and Drug Administration (FDA) recently approved to treat adults with metastatic non-small cell lung cancer that has a certain mutation in the MET gene. |
CAR T-Cell Therapy for Follicular Lymphoma
We’ve updated our drug summary for axicabtagene ciloleucel (Yescarta), a type of CAR T-cell therapy, to include a recent FDA approval for follicular lymphoma. |
